FDA Fields Advice for Reducing Opioid Risks

GAITHERSBURG, MD. — Recommendations for implementing Risk Evaluation and Mitigation Strategies for certain opioid pain medications ranged from passionate pleas for immediate action to measured advice for proceeding cautiously at a public meeting held by Food and Drug Administration officials.